Company

 

Raydient Oxymetry

Description

 

Developing a low-cost biomedical device to monitor the oxygen levels in fetal blood.

Status

 

Lead investors are reviewing diligence presented by Faz, and will be making a decision shortly.

Diligence

 

Yes

Lead

 

Faz Bashi

 

MobileODT

Disrupting the cervical cancer market using AI/ML to provide an alternative to the pap smear.

Darshana is reviewing the diligence package and determining next steps.

Yes

Darshana Zaver